Allogeneic hematopoietic cell transplantation improves outcome in myelodysplastic syndrome across high-risk genetic subgroups: genetic analysis of the Blood and …

J Versluis, W Saber, HK Tsai, CJ Gibson… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Allogeneic hematopoietic cell transplantation (HCT) in patients with
myelodysplastic syndrome (MDS) improves overall survival (OS). We evaluated the impact …

[HTML][HTML] Outlier expression of isoforms by targeted or total RNA sequencing identifies clinically significant genomic variants in hematolymphoid tumors

HK Tsai, T Gogakos, V Lip, JM Tsai, YD Li… - The Journal of Molecular …, 2023 - Elsevier
Recognition of aberrant gene isoforms due to DNA events can impact risk stratification and
molecular classification of hematolymphoid tumors. In myelodysplastic syndromes, KMT2A …

Targeting the deubiquitinase USP2 for malignant tumor therapy

S Zhang, Y Guo, S Zhang, Z Wang… - Oncology …, 2023 - spandidos-publications.com
The ubiquitin‑proteasome system is a major degradation pathway for> 80% of proteins in
vivo. Deubiquitylases, which remove ubiquitinated tags to stabilize substrate proteins, are …

[HTML][HTML] Characterizing the allele-specific gene expression landscape in high hyperdiploid acute lymphoblastic leukemia with BASE

J Andersson, E Aydın, R Gunnarsson, H Lilljebjörn… - Scientific Reports, 2024 - nature.com
Somatic copy number variations (CNVs), including abnormal chromosome numbers and
structural changes leading to gain or loss of genetic material, play a crucial role in initiation …

[HTML][HTML] Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia

BA Pitel, C Zepeda-Mendoza, Z Sachs, H Tang… - Blood cancer …, 2023 - nature.com
Dear Editors, Acute myeloid leukemia (AML) can be classified into multiple genetic subtypes
based on recurrent pathogenic structural variants (SVs), copy number abnormalities (CNAs) …

[HTML][HTML] Genomic Characterization of Partial Tandem Duplication Involving the KMT2A Gene in Adult Acute Myeloid Leukemia

A Seto, G Downs, O King, S Salehi-Rad, A Baptista… - Cancers, 2024 - mdpi.com
Simple Summary Genetic rearrangements of the KMT2A gene are associated with
diagnostic and prognostic outcomes in the context of myeloid neoplasms. While …

[HTML][HTML] Predicting leukemic transformation in myelodysplastic syndrome using a transcriptomic signature

C Guo, YY Gao, ZL Li - Frontiers in Genetics, 2023 - frontiersin.org
Background: For prediction on leukemic transformation of MDS patients, emerging model
based on transcriptomic datasets, exhibited superior predictive power to traditional …

Outlier expression of isoforms by targeted RNA sequencing as clinical markers of genomic variants in B lymphoblastic leukemia and other tumor types

HK Tsai, T Gogakos, V Lip, J Tsai, YD Li, A Fisch… - medRxiv, 2022 - medrxiv.org
Recognition of aberrant gene isoforms indicative of underlying DNA events can impact
molecular classification and risk stratification of B lymphoblastic leukemia (B-ALL). Aberrant …

[HTML][HTML] Myeloid malignancies' driver mutations-Part# 2: KMT2A, a gene for epigenetic regulation

OGT All - Technology, 2023 - ogt.com
Myeloid malignancies are influenced by various genetic and epigenetic influences,
manifested by excessive proliferation, abnormal self-renewal, and/or differentiation defects …

[HTML][HTML] Histone methyltransferase KMT2A: Developmental regulation to oncogenic transformation

J Ogino, Y Dou - Journal of Biological Chemistry, 2024 - Elsevier
Our current understanding of epigenetic regulation is deeply rooted in the founding
contributions of Dr. C. David Allis. In 2002, Allis and colleagues first characterized the lysine …